Skip to content
Neighborhood
Events & Culture
Transportation
Diversity
Future of Work
Kendall Collaborations
About
Join KSA
Menu
Neighborhood
Events & Culture
Transportation
Diversity
Future of Work
Kendall Collaborations
About
Join KSA
Announcements
Alnylam Pharmaceuticals won FDA approval for its third medicine in as many years. The drug, Oxlumo, is approved for a rare disorder called primary hyperoxaluria type 1, which can cause kidney and bladder stones.
Dec 01, 2020
Share
Share on Twitter
Share on Facebook
Close
Previous
←
Next
→
/